2021 ´ëÇÑÇ÷¾×ÇÐȸ CML ¿¬±¸È¸ Ãá°è ½ÉÆ÷Áö¾ö : 2021-04-24±³À°ÀÏÀÚ : 2021-04-24
±³À°Àå¼Ò : ¹Ð·¹´Ï¾ö ÈúÆ° ¼¿ï Topaz·ë
±³À°ÁÖÁ¦ :
2021 ´ëÇÑÇ÷¾×ÇÐȸ CML ¿¬±¸È¸ Ãá°è ½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¸¸¼º°ñ¼ö¼º¹éÇ÷º´¿¬±¸È¸
´ã´çÀÚ : À̺¸¿µ
¿¬¶ôó : 031-460-3226
À̸ÞÀÏ :
ksh.cml.wp.secr@gmail.com ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 40¸í
Èñ¸ÁÆòÁ¡ : 2Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 2 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í Äڷγª19·Î ¼±Âø¼ø 40ºÐ±îÁö µî·ÏÀ» ¹ÞÀ» ¿¹Á¤ÀÎ °ü°è·Î µî·ÏÀÌ Á¶±â¿¡ ¸¶°¨µÉ ¼ö ÀÖ½À´Ï´Ù.
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-24 Topaz 09:05~09:30 Treatment after failure of 2G TKI as first-line therapy ÀÌÁ¤¿Á(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04-24 Topaz 09:30~09:55 Allogeneic HSCT for CML ¾öÁöÀº(ÇѾçÀÇ´ë)
±³À°½Ã°£ 04-24 Topaz 10:20~10:40 First generation vs. Second generation TKI-which is best at diagnosis of CP-CML? ÃÖÀºÁö(¿ï»êÀÇ´ë)
±³À°½Ã°£ 04-24 Topaz 10:40~11:00 When is it safe to stop TKIs º¯ÀÚ¹Î(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04-24 Topaz 11:25~11:50 Biology and Pathophysiology ±ÇÁöÇö(ÃæºÏÀÇ´ë)
±³À°½Ã°£ 04-24 Topaz 11:50~12:15 Therapy ±è°æÇÏ(¼øõÇâÀÇ´ë)